Matt McKenzie

ICU/NST pharmacist @ the intersection of CC, ID, & oncology | always learning @MDAndersonNews | PGY2 CC RPC | @UK_HealthCare R485 | he/him 🏳️‍🌈

[UT MD Anderson @UTMDAnderson]

MD Anderson is proud to be named #1 in the nation for cancer care in @USNews’“Best Hospitals” ranking.

Read more: https://t.co/6DKYn4XAp5
#BestHospitals #EndCancer

[Scott Dietrich @PCC_PharmD]

ChatGPT less accurate than a pharmacist for DI questions

Job are still safe👍

https://t.co/z9fOmehshT

[Nicholas Morris @namorrismd]

New @neurocritical care society guideline: Sz ppx for nontraumatic #ICH. Panel suggests AGAINST use of ppx ASM for nontraumatic ICH and if ASM started, rec LEV for ≤ 7 days (as opposed to PHT/fPHT). https://t.co/BknNTeEGRu @NeurocritCareJ @MDNeurocritcare @UMDNeurosurgery

[NEJM @NEJM]

The OCEANIC-AF randomized trial of the factor XIa inhibitor asundexian was stopped early owing to a higher incidence of stroke or systemic embolism than with apixaban therapy among patients with atrial fibrillation. Full trial results: https://t.co/dZPaihNNp6

#ESCardio

[Matt McKenzie @mgm485]

Very proud of you @critcarekatie | PGY-Done! Wishing you all the best. Thanks for a great year. @MDAndersonNews @BDeePharmD @emilyhighsmith #pharmICU

[Michael Sirimaturos, PharmD, BCNSP, BCCCP, FCCM @MSirimaturos]

Want to learn how to improve the residency research process and publication rates? Then head over to @ASHPFoundation for my webinar talk on Flipped Research Models at 1 PM CST (2 PM EST). It’s not too late to register! https://t.co/mTaqMM8aZ5 #TwitterRx #PharmRes

[Matt McKenzie @mgm485]

Twitterless Emily Highsmith liberating us on the C of the ABCDEF bundle #ICULiberation #SCCMSoMe @MDAndersonNews

[Pharmacy To Dose: The Critical Care Podcast @PharmacyToDose]

🚨NEW POD ALERT🚨
Glycemic Control in the ICU: Part II
Ft. Michael Sirimaturos @MSirimaturos and
Judi Jacobi @judijacobi

2012 v. 2024 scope/PICO ?’s ⚔️
Effect of TGC-FAST 🕙
Role of CDS 🖥️
Becoming guideline panel members ✍️
Important future research topics 🏆
Biggest guideline changes 📰
& much more!

https://t.co/UoGK2GRBnF

https://t.co/aqvpsFTTio

https://t.co/yJi22gWQQT

[Matt McKenzie @mgm485]

@nancyclovir @AmpC_Stabler @MDAndersonNews @dont_joshme @jjjaiimee @LinK_PharmD @KelseyOlson33 Title is everything

[Pharmacy To Dose: The Critical Care Podcast @PharmacyToDose]

What role do Pharmacists play in immunotherapy? In short, A LOT.

Immunotherapy Part II with Matt McKenzie @mgm485 available now

https://t.co/1nnfS6o3QC

[Matt McKenzie @mgm485]

Someone was very into the theme today @emilyhighsmith #PharmICU #SCCMSoMe

[Pharmacy To Dose: The Critical Care Podcast @PharmacyToDose]

ICYMI: Immunotherapy Part II featuring Matt McKenzie is available now.

What exactly are CAR-T cells? This and so much more in the full episode

https://t.co/EX4jTX1FKE

[Pharmacy To Dose: The Critical Care Podcast @PharmacyToDose]

Blake Robbins highlights his ⭐️ Star Research abstract, and much more on the 2024 SCCM Congress: Sunday episode.

Available everywhere now: https://t.co/nAcJO00TAX

[Matt McKenzie @mgm485]

Super humbled to be a part of the pod. Thanks, @PharmacyToDose! #PharmICU

[Pharmacy To Dose: The Critical Care Podcast @PharmacyToDose]

🚨NEW POD ALERT🚨
Immunotherapy Part II
ft. Matt McKenzie @mgm485

Favorite CAR-T cell name 🏅
CRS v. ICANS ⚔️
Treatment considerations 🗒️
Common post-ICI ADE 🫁
Role of PharmD for ADE prevention/treatment 😷
Mattress Mack story 💸
& much more!

Come for the knowledge, stay for Matt’s impressive pronunciation skills 👏

https://t.co/UoGK2GRBnF

https://t.co/aqvpsFTTio

https://t.co/CdLwLLE34y

#pharmicu #medtwitter #twitterx #hemeonctwitter #cartcell #crs #icans #ici #foamed #some #meded

[Matt McKenzie @mgm485]

Listening to our ⭐️ PGY2 CC resident @critcarekatie as she presents her grand rounds on beta lactam-induced neurotoxicity #pharmICU #SCCMSoMe @MDAndersonNews

[Matt McKenzie @mgm485]

Great to be back in person @SCCM Congress. Super proud of our @SCCMTXChapter for winning the Chapters Alliance Award. Too many people to thank for making this happen! #sccm2024 #SCCMSoMe

[UK ICU Pharmacy @UKCritCarePharm]

🎉🥳 congratulations to UKHC CT surgery pharmacist and @UKPharmRes PGY2 RPD @camelpanda for being named a fellow of critical care medicine @SCCM #SCCM2024

[Matt McKenzie @mgm485]

Corticosteroid use based on severity of CAP implemented into the guidelines:

2024: recommend use in severe CAP

2017: previously recommended use in all hospitalized patients with CAP

[Matt McKenzie @mgm485]

SCCM Guideline update 2017 ➡️ 2024! 🚨 Corticosteroids in sepsis, ARDS, and CAP. #SCCM2024 #SCCMSoMe

[Matt McKenzie @mgm485]

Additionally, guidelines give suggested steroid dosing schemes based on timing.

Early ARDS (<24 hr): suggest DEXA-ARDS dosing (PMID: 32043986)

Early ARDS (<72 hr): suggest Meduri dosing (PMID: 9669790)

Unresolving ARDS (7-21 d): suggest Meduri dosing (PMID: 17426195)